CD8A and COVID-19: From the 52,728,647 CD8+ cells interrogated from acute and convalescent COVID-19 patients, we identified high-confidence TCR-peptide-HLA interactions across 434 immunogenic SARS-CoV-2-derived epitopes and 1,163 independent α/β TCR clonotypes (Fig. 1b, Data file S3).